With a market cap. of $8.6 billion, Corteva, Inc. (CTVA) is a global pure-play agriculture company that combines industry-leading innovation, customer engagement, and operational excellence to deliver solutions for key agricultural challenges worldwide. With a diverse portfolio of seeds, crop protection products, and digital services, Corteva aims to boost farm productivity, drive sustainable growth, and improve outcomes across the global food system.
The Indianapolis, Indiana-based company is expected to announce its fiscal Q3 2026 results after the market closes on Wednesday, Nov. 11. Ahead of this event, analysts forecast NOC to report an Operating EPS of $0.09, an improvement of 139.1% from a loss of $0.23 per share in the year-ago quarter. It has surpassed Wall Street's earnings estimates in each of the last four quarters.
More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.
For fiscal 2026, analysts predict the agricultural technology company to post an Operating EPS of $1.04, a decrease of 68.9% from $3.34 in fiscal 2025. However, Operating EPS is projected to grow 5.8% year-over-year to $1.10 in fiscal 2027.
www.barchart.com Shares of Corteva have dropped 78.9% over the past 52 weeks, lagging behind both the S&P 500 Index's ($SPX) 15.5% gain and the State Street Materials Select Sector SPDR ETF's (XLB) 15.7% return over the same period.
www.barchart.com Corteva’s shares dropped 11.9% following its Q2 2026 results on Jul. 30 as revenue of $6.38 billion missed analysts’ estimate. Seeds sales were flat at $4.53 billion, and Crop Protection sales declined 4% to $1.85 billion. Investors were also concerned that the shift from corn to soybeans could reduce demand for chemical-intensive crop-protection products in Q3, and high fertilizer and fuel costs continue to pressure farmers’ spending and margins.
Although the company raised its fiscal 2026 adjusted EPS outlook to $3.60 - $3.80 and expects operating EBITDA of $4.1 billion - $4.3 billion, the revenue miss and weaker near-term volume/margin outlook outweighed the improved profit guidance.
Analysts' consensus view on CTVA stock is cautiously optimistic, with a "Moderate Buy" rating overall. Among 21 analysts covering the stock, 13 recommend "Strong Buy," two suggest "Moderate Buy," five have a "Hold," and one advises "Strong Sell." This configuration is slightly more bullish than three months ago, with 12 analysts suggesting a "Strong Buy."
The average analyst price target is $16.92, suggesting a potential upside of 31.4% from current levels.
On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
Goldman vs. JPMorgan: Both Raised Their Dividends. Which Bank Is the Better Buy? Lockheed Martin's $88 Billion Missile Backlog Could Be a Reason to Buy Before October 22 Applied Materials Just Opened a $5 Billion R&D Center. What That Actually Means for AMAT Stock. PEP Stock Alert: KFC Just Dealt PepsiCo a Blow With New Coca-Cola Deal